Skip to main content
Clinical Trials/CTRI/2018/02/011848
CTRI/2018/02/011848
Completed
Phase 3

A study to evaluate the results of integrative treatment for vascular disease: namely: Cerebrovascular accident - embolic and atherosclerotic, (CAV), CAD, DVT,PAD

Health Solutions0 sites156 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Health Solutions
Enrollment
156
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 1, 2017
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Health Solutions

Eligibility Criteria

Inclusion Criteria

  • 1\. Existing and New patients of SKNMC \& GH OPD and IPD, coming to and receiving treatment for symptoms of atherosclerosis, vascular disease complications including IHD, CVA, Stroke, DVT, CAD.

Exclusion Criteria

  • 1\) Pregnant and lactating women,
  • 2\) Patients below age of 18
  • 3\) Acute IPD operative condition
  • 4\) Patients undergoing intervention procedures / surgical treatments other than for Vascular disease; until they are discharged from intensive care
  • 5\) Haemorrhagic cerebro vascular stroke.

Outcomes

Primary Outcomes

Not specified

Similar Trials